Asclera

NDC 67850-140 · Methapharm, Inc

Generic namePOLIDOCANOL

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)POLIDOCANOL

Strength.005 g/mL

Pharmacologic classSclerosing Activity [MoA], Sclerosing Agent [EPC], Vascular Sclerosing Activity [PE]

Marketing categoryNDA

Packages

67850-140-05 — 2 mL in 1 AMPULE (67850-140-05)

FDA lists these products with the same active ingredient.

67850-141 — POLIDOCANOL

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.